Cite
HARVARD Citation
Busse, W. et al. (2021). Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet. 9 (10), pp. 1165-1173. [Online].